Delivery Order SPE2DB22D3011-SPE2DB24FP7WE

Award Date 11/30/23
Potential Completion Date 12/1/23
Potential Value $3.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $26,445.67 Firm Fixed Price Delivery Order for the supply of XARELTO 15 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of May 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $8,213.47 for the supply of XARELTO 15 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Xarelto 20 mg tablets. The $13,502.78 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA) on December 27, 2022, with a completion date of December 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,553.43 firm-fixed-price delivery order is for the supply of XARELTO 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a pharmaceutical product called XARELTO 20 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $20,068.96 and an ultimate completion date of March 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $43,674.56 for the supply of XARELTO 20 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. government, and has an ultimate completion date of February 22, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DX23FUSPF) valued at $8,528.09 for the supply of 90 tablets of the prescription medication Xarelto 20 mg. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of April 18, 2023. The contract utilizes a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,866.87 Firm Fixed Price delivery order is for the supply of 4562841998 - XARELTO 20 MG TABLET 90S, with a performance period through November 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $21,486.26 firm fixed-price delivery order is for the supply of the pharmaceutical product Xarelto 20 mg tablets. The contract has an ultimate completion date of February 28, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Xarelto 20 mg tablets. The $3,680.95 Firm Fixed Price delivery order was placed by the Defense Logistics Agency (DLA) and has a completion date of December 9, 2021. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FP7WE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The $3,713.04 firm fixed-price delivery order was awarded by the Defense Logistics Agency, a defense agency, and has an ultimate completion date of December 1, 2023.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. Additionally, the company maintains a separate $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/12/25, 9:43 AM